Organoids have become a prevalent tool to bridge the gap between cell and human studies. A new organoid study uncovers chronic pancreatitis development and identifies possible therapeutic strategies. The post Chronic Pancreatitis Therapies Informed by Patient-Derived Organoids appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
Sophie Spencer
NICE backs finerenone for heart failure
Biogen and Eisai’s Leqembi study shows nearly 83% of...
Alzheimer’s groups call for urgent global focus on...
Modular Modeling Drives Smarter mRNA Manufacturing
Free-Floating Bioelectronic Sensors for Fermentation...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
